Compare YDDL & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YDDL | BCYC |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | Philippines | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.9M | 296.0M |
| IPO Year | N/A | 2019 |
| Metric | YDDL | BCYC |
|---|---|---|
| Price | $2.09 | $4.34 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $13.90 |
| AVG Volume (30 Days) | 32.9K | ★ 647.2K |
| Earning Date | 04-27-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $40.85 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.95 | $3.92 |
| 52 Week High | $16.23 | $9.18 |
| Indicator | YDDL | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 26.24 | 56.05 |
| Support Level | N/A | $4.25 |
| Resistance Level | $3.03 | $4.75 |
| Average True Range (ATR) | 0.27 | 0.17 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 13.02 | 90.53 |
One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.